Platify 25mg Tablet

1. Product Introduction:

Platify 25mg Tablet is a prescription medication that contains Eltrombopag, a thrombopoietin receptor agonist. It is primarily used to treat low platelet counts (a condition known as thrombocytopenia) in patients with specific blood-related disorders. Platelets are crucial components of blood that help in clotting and preventing excessive bleeding. A deficiency of platelets can result in spontaneous bleeding and other complications.

Eltrombopag works by stimulating the bone marrow to produce more platelets. Platify 25mg is not a chemotherapy or steroid medicine—it is a targeted therapy specifically designed to manage diseases where platelet production is suppressed or impaired. It is taken orally and typically used under the supervision of a hematologist or oncologist, depending on the underlying condition.

2. Uses of This Medicine:

Platify 25mg Tablet is prescribed for several platelet-deficiency disorders, including:

• Chronic Immune Thrombocytopenia (ITP):
  Used in adult and pediatric patients aged 1 year and above with ITP who have not responded well to first-line treatments like corticosteroids, immunoglobulins, or splenectomy.

• Thrombocytopenia Associated with Hepatitis C:
  Used in patients with chronic Hepatitis C to maintain appropriate platelet levels and allow for interferon-based antiviral therapy.

• Severe Aplastic Anemia (SAA):
  Indicated in adults with acquired SAA who have not responded to immunosuppressive therapy or are receiving it in combination with other first-line agents.

Platify 25mg is not used for chemotherapy-induced thrombocytopenia or myelodysplastic syndromes unless specified by a healthcare professional.

3. Benefits of This Medicine:

• Increases Platelet Production:
  The main benefit of Platify is its ability to stimulate platelet production in the bone marrow, reducing the risk of bleeding episodes.

• Reduces Need for Transfusions:
  It helps maintain an adequate platelet count, thus decreasing the requirement for platelet transfusions, especially in aplastic anemia patients.

• Supports Antiviral Therapy in Hepatitis C Patients:
  Enables patients with Hepatitis C to continue interferon-based therapies by managing interferon-induced thrombocytopenia.

• Improves Quality of Life:
  Regular use can lead to fewer bleeding episodes, enhanced physical functioning, and a better overall lifestyle.

• Convenient Oral Administration:
  Platify is taken by mouth, offering convenience over injectable therapies or frequent hospital visits.

4. Side Effects:

While Platify 25mg Tablet is generally well-tolerated, some side effects may occur. It is important to report any unusual symptoms to your healthcare provider.

Common Side Effects:

• Headache

• Fatigue

• Nausea

• Diarrhea

• Muscle pain

• Cough or respiratory symptoms

Less Common but Serious Side Effects:

• Liver Toxicity:
  Elevated liver enzymes or liver damage. Regular liver function monitoring is necessary.

• Thromboembolic Events:
  Excess platelet counts may increase the risk of blood clots. Immediate medical attention is required for symptoms like leg swelling, chest pain, or sudden shortness of breath.

• Eye Problems:
  Long-term use may be associated with cataract formation—eye exams are recommended during prolonged treatment.

• Bone Marrow Changes:
  In rare cases, abnormal bone marrow function may occur, especially with extended use.

5. Frequently Asked Questions (FAQ):

Q1. What is Platify 25mg Tablet used for?
A1. Platify is used to treat low platelet counts in conditions like chronic ITP, hepatitis C-related thrombocytopenia, and severe aplastic anemia.

Q2. How does Eltrombopag in Platify work?
A2. Eltrombopag stimulates thrombopoietin receptors in the bone marrow, increasing the production of platelets.

Q3. When will I start seeing results after taking Platify?
A3. Some patients see improvement in platelet counts within 1 to 2 weeks, but it may vary. Regular blood monitoring is necessary to assess effectiveness.

Q4. Can Platify be given to children?
A4. Yes, it is approved for use in children aged 1 year and older for ITP if they haven’t responded to conventional therapies.

Q5. Is Platify safe during pregnancy?
A5. Use during pregnancy is not recommended unless clearly needed and prescribed by a doctor. Women should use effective contraception during treatment.